[EN] JAK P13K/mTOR COMBINATION THERAPY<br/>[FR] POLYTHÉRAPIE PAR JAK P13K/MTOR
申请人:NOVARTIS PHARMA AG
公开号:WO2013023119A1
公开(公告)日:2013-02-14
Provided herein is a combination therapy comprising a JAK kinase inhibitor and a dual PBK/mTOR inhibitor, as well as methods of treating various cancers through the use of such a combination therapy.